Collegium Pharmaceutical (COLL) Deferred Taxes (2021 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Deferred Taxes of -$968000.0 for Q1 2026, down 79.59% year-over-year from -$4.7 million in Q1 2025, and up 90.39% quarter-over-quarter from -$10.1 million in Q4 2025.
Collegium Pharmaceutical (COLL) Deferred Taxes (2021 - 2026) Analysis & Trends
Collegium Pharmaceutical's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$968000.0 for Q1 2026.
- In Q1 2026, Deferred Taxes fell 79.59% year-over-year to -$968000.0; the TTM figure through Mar 2026 stood at -$26.1 million (down 13.71% YoY), while the FY2025 annual figure was -$25.7 million, up 4.31% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$968000.0, up from -$10.1 million in the prior quarter.
- The five-year high for Deferred Taxes was $2.1 million in Q3 2022, with the low at -$12.1 million in Q3 2025.
- The 5-year median for Deferred Taxes is -$2.9 million (2025), against an average of -$3.8 million.
- The sharpest annual moves came in 2022 and 2024: Deferred Taxes jumped 656.23% in 2022, then sank 9491.3% in 2024.
- Collegium Pharmaceutical's Deferred Taxes stood at -$1.1 million in 2022, then jumped by 68.65% to -$338000.0 in 2023, then tumbled by 2904.73% to -$10.2 million in 2024, then rose by 0.83% to -$10.1 million in 2025, then surged by 90.39% to -$968000.0 in 2026.
- Business Quant data shows COLL's Deferred Taxes at -$968000.0 in Q1 2026, -$10.1 million in Q4 2025, and -$12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn | -7.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.16 Mn |
| Mar 31, 2026 | -968,000.00 |
| Dec 31, 2025 | -10.07 Mn |
| Sep 30, 2025 | -12.13 Mn |
| Jun 30, 2025 | -2.91 Mn |
| Mar 31, 2025 | -539,000.00 |
| Dec 31, 2024 | -10.16 Mn |
| Sep 30, 2024 | -8.73 Mn |
| Jun 30, 2024 | -3.51 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Dec 31, 2023 | -338,000.00 |
| Sep 30, 2023 | -1.13 Mn |
| Jun 30, 2023 | -636,000.00 |
| Mar 31, 2023 | -46,000.00 |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | -3.37 Mn |
| Mar 31, 2022 | -6.04 Mn |
| Dec 31, 2021 | -15.02 Mn |
| Sep 30, 2021 | -377,000.00 |